Amgen's Blincyto Data Send Cullinan Higher
Seeking Alpha15:39 ET
Amgen to Seek European OK of Thyroid Eye Disease Drug Tepezza
By Colin Kellaher Amgen plans to seek European regulatory approval for the sale of its blockbuster Tepezza treatment for thyroid eye disease. The Thousand Oaks, Calif., biotechnology company on Frid
WSJApr 26 09:22 ET
Amgen Seeks EMA Approval For Teprotumumab In Moderate To Severe Thyroid Eye Disease
Amgen (NASDAQ:AMGN) today announced the imminent submission of a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for teprotumumab, a fully human monoclonal antibody an
BenzingaApr 26 09:02 ET
Express News | Amgen to Submit Teprotumumab Marketing Authorization Application to the European Medicines Agency
ReutersApr 26 09:00 ET
Express News | EMA Says Chmp Adopted Positive Opinions for Wezenla for Treatment of Plaque Psoriasis, Including Paediatric Plaque Psoriasis, Psoriatic Arthritis
ReutersApr 26 07:07 ET
20 Fastest Growing Health Tech Companies in the World
Yahoo FinanceApr 25 11:34 ET
Some Shareholders Feeling Restless Over Amgen Inc.'s (NASDAQ:AMGN) P/E Ratio
When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") below 16x, you may consider Amgen Inc. (NASDAQ:AMGN) as a stock to potentially avoid with its 21.8x P/E
Simply Wall StApr 25 06:33 ET
Why Is Cullinan Therapeutics Stock Trading Higher On Wednesday?
A recent academic case study, published on April 22, examined using Amgen Inc's (NASDAQ:AMGN) Blincyto, a bispecific CD3xCD19 T-cell engager, to treat a patient with severe systemic sclerosis. The fin
BenzingaApr 24 14:29 ET
TikTok to Restrict Weight Loss Drug Promotion
Popular social media platform TikTok is cracking down on most content related to weight loss drugs starting next month, according to the video-sharing site's new community guidelines published last week.
Seeking AlphaApr 23 11:26 ET
Why Amgen (AMGN) Outpaced the Stock Market Today
Yahoo FinanceApr 22 17:50 ET
Goldman's Debt Issuers Stocks Basket
Seeking AlphaApr 22 12:53 ET
10 Best Performing Biotech ETFs in 2024
Yahoo FinanceApr 22 11:10 ET
Dividend Yield and Growth Stock List by Goldman
Seeking AlphaApr 22 11:04 ET
More contests are coming! Global Data: 13 new weight loss drugs are expected to be launched by 2029
Pharmacists are preparing to launch around 13 new weight loss treatments in the US within the next five years due to a surge in demand for weight loss products, according to a new report from global data analysis and consulting firm Global Data.
Zhitong FinanceApr 22 03:29 ET
13 New Obesity Drugs Could Hit the Market by 2029 Amid Surging Demand
Drugmakers are preparing to launch an estimated 13 new weight-loss treatments in the U.S. over the next five years amid surging demand for the products, according to a new report by Global Data.
Seeking AlphaApr 21 20:04 ET
How Is The Market Feeling About Amgen?
Amgen's (NYSE:AMGN) short percent of float has fallen 5.77% since its last report. The company recently reported that it has 10.47 million shares sold short, which is 1.96% of all regular shares that
BenzingaApr 19 09:45 ET
Amgen Is Maintained at Neutral by UBS
Amgen Is Maintained at Neutral by UBS
Dow JonesApr 18 07:41 ET
Amgen Price Target Cut to $284.00/Share From $314.00 by UBS
Amgen Price Target Cut to $284.00/Share From $314.00 by UBS
Dow JonesApr 18 07:41 ET
Amgen (AMGN) Suffers a Larger Drop Than the General Market: Key Insights
Yahoo FinanceApr 17 18:00 ET
Express News | Amgen Inc Says CEO Robert a. Bradway's 2023 Total Compensation Was $22.6 Mln Vs $21.4 Mln in 2022 – SEC Filing
Moomoo 24/7Apr 17 16:05 ET
No Data
No Data